The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology task force on antibiotic resistance

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 4, 1996, Pages 153-161

  Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CEPHAMYCIN; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; MACROLIDE; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAMETHOXAZOLE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; HUMAN; INFECTION CONTROL; MEDICAL EDUCATION; PRIORITY JOURNAL; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; DATA COLLECTION; DRUG RESISTANCE, MULTIPLE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GUIDELINES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGY; RESEARCH; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0030221479     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00099-5     Document Type: Conference Paper

References (54)

1. Aldridge KE, Gelfand MS, Schiro DD, Brag NL (1992) The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents. Diagn Microbiol Infect Dis 15:601-608.
2. American Society for Microbiology (1995) Report of the ASM Task Force on antibiotic resistance. Antimicrob Agents Chemother (Suppl):1-23.
3. Applebaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15:77-83.
4. Archer GL, Climo MW (1994) Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 38:2231-2237.
5. Arthur M, Courvalin P (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37:1563-1571.
6. Baquero F (1995) Evolution of susceptibility in respiratory tract bacterial pathogens in US and Europe: the third year of the Alexander Project [Abstr LB-23]. In Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Francisco, CA: ASM.
7. Baquero F, Martinez-Beltran J, Loza E (1991) A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 28(Suppl C):31-38.
8. Baron EJ, Jones RN (1995) National survey of the in vitro spectrum of piperacillin-tazobactarn tested against more than 40,000 aerobic clinical isolates from 236 medical centers. Diagn Microbiol Infect Dis 21:141-151.
9. Berkelman RL, Bryan RT, Osterholm MT, LeDuc JW, Hughes JM (1994) Infectious disease surveillance: a crumbling foundation. Science 264:368-370.
10. Blumberg HM, Rimland D, Carroll DJ, Tarry P, Wachsmuth IK (1991) Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis 163:1279-1285.
11. Bochud PY, Eggiman P, Calandra T, Van Melle G, Saghafi L, Francioli P (1994) Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 18:25-31.
12. Burwen DR, Banerjee SN, Gaynes RP, and the National Nosocomial Infections Surveillance System (1994) Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 170:1622-1625.
13. Bush K (1989a) Characterization of β-lactamases. Antimicrob Agents Chemother 33:259-263.
14. Bush K (1989b) Classification of β-lactamases: groups 1,2a, 2b, and 2b′. Antimicrob Agents Chemother 33:264-270.
15. Bush K (1989c) Classification of β-lactamsaes: groups 2c, 2d, 2e, 3, and 4. Antimicrob Agents Chemother 33:271-276.
16. Cassell GH (1994) New and emerging infections in the face of a funding crisis. ASM News 60:251-254.
17. Centers for Disease Control (1994) Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary. MMWK Morb Mortal Wkly Rep 43(RR-5):1-18.
18. Eliopoulos GM (1993) Increasing problems in the therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis 12:409-412.
19. Ervik A, Thorsen B, Eriksen V, Lunstad VT, Samuelsen OB (1994) Impact of administering antibacterial agents on wild fish and blue mussels Mytilus edulis in the vicinity of fish farms. Dis Aquat Org 18:45-51.
20. Federal Register (1994) Preventing the spread of vancomycin resistance: quarterly report from the Hospital Infection Control Practices Advisory Committee. Fed Reg 59: 25758-25763.
21. Hughes JH, Biedenbach DJ, Erwin ME, Jones RN (1993) Etest as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J Clin Microbiol 31:3255-3259.
22. Institute of Medicine (1989) Human Health Risks with the Subtherapeutic Use of Penicillin or Tetracydines in Animal Feed. Washington, DC: National Academy Press.
23. Jacoby GA (1994) Genetics of extended-spectrum betalactamases. Eur J Clin Microbiol Infect Dis 13:S2-S11.
24. Jacoby GA, Carreras I (1990) Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 34: 858-862.
25. Johnson CC, Slavoski L, Schwartz M, May P, Pitsakis PG, Shur AL, Levison ME (1995) In vitro activity of RP-59500 (quinupristin/dalfopristin) against antibioticresistant strains of Streptococcus pneumoniae and enterococci. Diagn Microbiol Infect Dis 21:169-173.
26. Jones RN (1992) The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn Microbiol Infect Dis 15:3S-10S.
27. Jones RN, Barry AI, Gardiner RV, Packer RR (1989) The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagn Microbiol Infect Dis 12:385-394.
28. Jones RN, Erwin ME, Anderson SC (1995a) Emerging multiple resistant enterococci among clinical isolates: II. Validation of the Etest to recognize glycopeptide resistant strains. Diagn Microbiol Infect Dis 21:95-100.
29. Jones RN, Kehrberg EN, Erwin ME, Anderson SC, and the Fluoroquinolone Resistance Surveillance Group (1994) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistance: real or perceived? Diagn Microbiol Infect Dis 19:203-215.
30. Jones RN, Sader HS, Erwin ME, Anderson SC, and the Enterococcus Study Group (1995b) Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 21:85-93.
31. Jordens JZ, Slack MPE (1995) Haemophilus influenzae: then and now. Eur J Clin Microbiol Infect Dis 14:935-948.
32. Kunin CM (1993) Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 118:557-561.
33. Lee LA, Threatt VL, Puhr ND, Levine P, Ferris K, Tauxe RV (1993) Antimicrobial-resistant Salmonella spp. isolated from healthy broiler chickens after slaughter. J Am Vet Med Assoc 202:752-755.
34. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV (1994) Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 170:128-134.
35. McCaig LF (1994) National hospital ambulatory medical care survey: 1992 emergency department summary. Advance data from vital and health statistics. No. 245. Hyattsville, MD: National Center for Health Statistics.
36. McCaig LF, Hughes JM (1995) Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 273:214-219.
37. Moellering RC Jr (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14:1173-1176.
38. Murray PR, Cantrell HF, Lankford RB, and the In Vitro Susceptibility Surveillance Group (1994) Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic Gram-positive and Gram-negative bacteria. Diagn Microbiol Infect Dis 19:111-120.
39. Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3:46-65.
40. National Committee for Clinical Laboratory Standards (NCCLS) (1993a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M7-A3. Villanova, PA: NCCLS.
41. National Committee for Clinical Laboratory Standards (NCCLS) (1993b) Performance standards for antimicrobial disk susceptibility testings: approved standard M2-A5. Villanova, PA: NCCLS.
42. National Committee for Clinical Laboratory Standards (NCCLS) (1993c) Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard M11-A3. Villanova, PA: NCCLS.
43. National Committee for Clinical Laboratory Standards (NCCLS) (1994) Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard M23-A. Villanova, PA: NCCLS.
44. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Information supplement M100-S6. Villanova, PA: NCCLS.
45. Noble WC, Virani Z, Cree RGA (1992) Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 93:195-198.
46. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Toison JS, Markone WJ (1992) Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 13:582-586.
47. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, Facklan RR, Boxerbaum B, May D, Walton RO, et al. (1992) The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 166:1346-1353.
48. Rittenhouse SF, Miller LA, Kaplan RL, Mosely GH, Poupard JA (1995) A survey of β-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diagn Microbiol Infect Dis 21:223-225.
49. Rockefeller University Workshop (1994) Special report. Multiple-antibiotic resistant pathogenic bacteria. N Engl J Med 330:1247-1251.
50. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN (1994) Evaluation and characterization of multiresistant Enterococcus faecium from 12 US medical centers. J Clin Microbiol 32:2840-2842.
51. Schaberg DR, Culture DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91(Suppl 3B):72S-75S.
52. Schwalbe RS, Stapleton JT, Gilligan PH (1987) Emergence of vancomycin resistance in coagula se-negative staphylococci. N Engl J Med 316:927-931.
53. Swartz MN (1994) Hospital-acquired infections: Diseases with increasingly limited therapies. Proc Natl Acad Sci USA 91:2420-2427.
54. Woodford N, Johnson AP, Morrison D (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8:585-615.